From the Food and Drug Administration.
Nightingale
S C
SC
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy; D000212:Acyclovir / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D015774:Ganciclovir; D006801:Humans; D015215:Zidovudine / Q000009:adverse effects
D000998:Antiviral Agents; D004921:Erythropoietin; D015215:Zidovudine; D015774:Ganciclovir; D000212:Acyclovir